JR11 - Round table - Paul LINGOR

JR11 - Round table - Paul LINGOR

🎙 Paul Lingor 👥 1K 📅 January 28, 2026 ⏱ 17 min 👁 13 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

presymptomatic ALSgene mutation carriersbiomarkerssmell testclinical trial

Summary

Paul Lingor presents the premodiALS study, an international collaborative effort to study presymptomatic carriers of ALS gene mutations. The study aims to identify biomarkers and clinical features that precede symptom onset. It collects biospecimens (blood, CSF, urine, tears) with rigorous SOPs across multiple countries. Preliminary findings show a significant decline in smell perception in early ALS patients, particularly in SOD1 mutation carriers. The study also uses questionnaires to assess risk factors and environmental exposures, revealing associations with neurologist visits, weight loss, physical activity, and substance use. The protocol is designed to be lean and collaborative, with open access to SOPs and materials. Future plans include adding speech analysis using AI. The presentation highlights the importance of international collaboration and the challenges of recruiting presymptomatic individuals.

125 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the design and preliminary results of a large-scale study on presymptomatic ALS. The argumentation is based on data from the study, with appropriate caveats about small sample sizes and ongoing analyses. The speaker emphasizes the importance of rigorous SOPs and collaboration, which strengthens the credibility of the findings.

Scientific Rigor, Source Quality, Title Accuracy

The study is well-designed with predefined analyses and collaborations with experts. The sources cited include the published protocol and collaborations with researchers like Mary Lewis Rogers and Nick Ashton. The title accurately reflects the content, and the presentation is scientifically rigorous, though preliminary data should be interpreted with caution.

118 words

Title / Content Match

The title accurately reflects the content: a round table presentation on presymptomatic ALS gene mutation carriers.

Quality & Reliability

7/10

Presentation of ongoing research with preliminary data, transparent about limitations, but lacks peer review and detailed methodology.

Key Moments

Cited Sources

  • premodiALS protocol publication — Mentioned as published protocol, but no specific URL provided.
  • Mary Lewis Rogers — Collaboration on P75 extracellular domain detection in urine.
  • Nick Ashton — Collaboration on new LISA analysis.

Concurring Sources

  • Benatar et al. Pre-familial ALS study — Referenced as exemplary biomarker study in presymptomatic ALS.

Contribution & Novelties

The premodiALS study provides a unique platform for studying presymptomatic ALS, with a focus on harmonized data collection and open collaboration. The preliminary finding of smell loss in SOD1 carriers is novel and warrants further investigation.

Pour aller plus loin :

77 words

Radar Profile

The radar profile shows balanced scores across all dimensions, indicating a well-rounded presentation with solid information quality and technical depth, though not exceptional in any single area.

Reliability 7/10

💬 No comments were provided for analysis.